Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ATIS is on the move! -- Ignore unavailable to you. Want to Upgrade?

To: WWS who wrote (1312)	1/26/1998 11:06:00 PM
From: Marshall Teitelbaum	Read Replies (1) \| Respond to of 2205

Bill, There was also a short release today from Boston boston.com Options make for interesting playing right now. The price has backed down at this point enough to cause options to be fairly reasonably priced given the proximity of the meeting, so if the news is good and they do shoot up a few points, calls are likely to be up significantly...of course, the risks are obvious, too. Guess we should have an answer about the panel by @12:30pm on thursday fwiw. Also, the atis website is supposed to up and running on thursday more than likely....likely an easy enough day to remember, and quite possibly a day where many could be wanting to look for further investment research, assuming the news is good...coincidentally, the panel happens to occur thursday, too. :) Talk to you later, MLT

To: WWS who wrote (1312)	1/28/1998 4:28:00 PM
From: IngotWeTrust	Respond to of 2205

Hi, Bill, thx 4 Ur reply. RE: me/ATIS options, no, I'm not playing it that way for 29th. My research into FDA plays shows that, while, yes, FDA approval means a pop in a stock, AFTER the FDA approval is a given, there is time to get into a stock and GOOD money to be made. Since my definition of risk management includes not trying to get the first buck nor the last, but to take some bucks outta das mitte...I take the lesser risk route of after approval. Thx for the heads up about Barrons and ORG article. I don't subscribe, so I'd have missed that op ed piece. Good Investing! O/49r